Test 3: 43 neuromuscular Flashcards
why use neuromuscular blocking agents
make tracheal intubation easier
reduced skeletal muscle tone at lighter anesthetic planes
prevention of patient movement
keeps eyes in place
control respiration
does not provide analgesia, may need to ventilate if diaphragm is affected, does not affect consciousness
ACh binds to — receptor on the muscle cell
nicotinic cholinergic receptors
2 ACh binds to ion channel that lets Na, Ca in and K out
what breaksdown ACh
Acetylcholinesterase (AChE) rapidly hydrolyzes ACh
how does NMJ work
Action potential arrives at the pre-junctional motor nerve ending → nerve terminal depolarizes → adenylate cyclase converts ATP to cyclic AMP → Ca2+ enters into the nerve terminal → causes release of ACh into the synaptic cleft → ACh binds to the post-junctional receptor → Ion channels open; sodium, calcium influx, potassium effluxes → post-junctional muscle cell is depolarized → ACh is hydrolyzed by acetylcholinesterase, removed from the receptor, and
repolarization occurs
how do depolarizing agents work
mimic ACh- cause prolonged depolarization and activation of channels
Phase 1: bind and cause fasciculations
Phase II: Ach receptors become desensitized → flaccid paralysis
how do non-depolarizing agent work
bind ACh but cannot induce the conformational
change needed to open the ion channel
- No phase 1 block- no AP is made
- NMB can occur even even if only one a-subunit is blocked- decouples AP transmission and muscular contraction, causing paralysis
- Function as ACh receptor competitive antagonists, outcompete ACh based on concentration
- Success of NMB depends on the concentration of NMBA vs concentration of ACh
— is a depolarizing NMBA
succinylcholine
only small amount gets to NMJ, because it is apidly hydrolyzed by the enzyme pseudocholinesterase (plasma cholinesterase) that are made by the liver
causes transient paralysis as drug diffuses away
Greater dose administered= faster onse
pancuronium
aminosteroid non depolarizing NMBA
- Onset is about 5 mins, duration of action 40-50 mins
- Also blocks cardiac muscarinic receptors, causing ↑HR
atracurium is a — NMDA
short acting non depolarizing NMDA
(Benzylisoquinolones)
what is hofmann elimination
spontaneous degradation without enzymes; temperature and pH- dependent
Atracurium- short-acting non-depolarizing NMBA
how is atracurium broken down
Hofman elimination- spontaneous degradation without enzymes; temperature and pH-dependent
Can give to patients with hepatic or renal insufficiency without increasing duration of action
Atracurium- short-acting non-depolarizing NMBA
Cisatracurium
4x potency of atracurium and even further reduced histamine release compared to atracurium though has similar onset and duration of action, 5 mins and duration is about 30 min
Also undergoes Hofmann elimination
short-acting non-depolarizing NMBA
vecuronium
devoid of cardiovascular effects (no tachycardia, no histamine release)
More than half of the drug undergoes hepatic metabolism with the remaining portion undergoing renal excretion
Both rocuronium and vecuronium have the advantage of being reversed by suggamadex
short-acting non-depolarizing NMBA
rocuronium
derivative of vecuronium with 1/8th potency
Administered as a larger dose and thus has a faster onset though still not as fast as succinylcholine; duration of action around 40 mins
Both rocuronium and vecuronium have the advantage of being reversed by suggamadex
short-acting non-depolarizing NMBA
Guaifenesin
Disrupts nerve impulse transmission at the level of the interneurons of the
spinal cord, brainstem, and subcortical areas
- Relaxation of skeletal muscle with little effect on respiratory muscles/diaphragm at therapeutic doses
- Produces neither analgesia nor unconsciousness
- Cannot antagonize
- 10% concentration can cause hemolysis, hemoglobinuria, or venous thrombosis; 5% concentration ‘safe’
- Damaging to tissues if extravasates
- Crosses blood-placenta barrier
- Most commonly used in field anesthesia as part of a ‘triple drip’